Kairos Pharma Statistics Share Statistics Kairos Pharma has 20.46M
shares outstanding. The number of shares has increased by 31.21%
in one year.
Shares Outstanding 20.46M Shares Change (YoY) 31.21% Shares Change (QoQ) 22.98% Owned by Institutions (%) n/a Shares Floating 8.65M Failed to Deliver (FTD) Shares 5,690 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 198.17K, so 1.18% of the outstanding
shares have been sold short.
Short Interest 198.17K Short % of Shares Out 1.18% Short % of Float 1.96% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -6.63 and the forward
PE ratio is -2.9.
Kairos Pharma's PEG ratio is
-0.19.
PE Ratio -6.63 Forward PE -2.9 PS Ratio 0 Forward PS n/a PB Ratio 3.61 P/FCF Ratio -4.36 PEG Ratio -0.19
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kairos Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.2,
with a Debt / Equity ratio of 0.
Current Ratio 4.2 Quick Ratio 4.2 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.6M Employee Count 1 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 2.06, so Kairos Pharma's
price volatility has been higher than the market average.
Beta 2.06 52-Week Price Change n/a 50-Day Moving Average 0.75 200-Day Moving Average 1.12 Relative Strength Index (RSI) 58.88 Average Volume (20 Days) 5,189,796
Income Statement
Revenue n/a Gross Profit n/a Operating Income -2.34M Net Income -2.6M EBITDA -2.34M EBIT -2.64M Earnings Per Share (EPS) -0.23
Full Income Statement Balance Sheet The company has 1.27M in cash and 0 in
debt, giving a net cash position of 1.27M.
Cash & Cash Equivalents 1.27M Total Debt n/a Net Cash n/a Retained Earnings -8.81M Total Assets 7.94M Working Capital 5.25M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.96M
and capital expenditures 0, giving a free cash flow of -3.96M.
Operating Cash Flow -3.96M Capital Expenditures n/a Free Cash Flow -3.96M FCF Per Share -0.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
